- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · May 5, 2025 | 25M sh |
| Shares Diluted | FY 2024 · Dec 31, 2023 | 25M sh |
| Capex | FY 2024 · Dec 31, 2023 | $295.49K |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | −$1.39M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $443.76K |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $5.96M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $6.75M |
| Current Assets | FY 2024 · Dec 31, 2023 | $1.5M |
| Total Assets | FY 2024 · Dec 31, 2023 | $4.84M |
| Eps Diluted | FY 2024 · Dec 31, 2023 | −$0.08 |
| Eps Basic | FY 2024 · Dec 31, 2023 | −$0.08 |
| Sga Expense restated | FY 2024 · Dec 31, 2023 | $1.9M |
| Net Income | FY 2024 · Dec 31, 2023 | −$2.09M |
| Operating Income | FY 2024 · Dec 31, 2023 | −$2.5M |
| Revenue | FY 2024 · Dec 31, 2023 | $4.09M |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | −$466.19K |